{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:30:26Z","timestamp":1774438226355,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1245\/s10434-018-6420-y","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T10:41:16Z","timestamp":1520419276000},"page":"1471-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The C-Reactive Protein\/Albumin Ratio May Predict the Long-Term Outcome in Patients with Malignant Pleural Mesothelioma"],"prefix":"10.1245","volume":"25","author":[{"given":"Naoya","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"6420_CR1","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.21037\/jtd.2017.11.55","volume":"9","author":"E Taioli","year":"2017","unstructured":"Taioli E, van Gerwen M, Mihalopoulos M, Moskowitz G, Liu B, Flores R. Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery. J Thorac Dis. 2017;9:5423\u201333.","journal-title":"J Thorac Dis."},{"key":"6420_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.21037\/tlcr.2017.06.01","volume":"6","author":"MR Mancuso","year":"2017","unstructured":"Mancuso MR, Neal JW. Novel systemic therapy against malignant pleural mesothelioma. Transl Lung Cancer Res. 2017;6:295\u2013314.","journal-title":"Transl Lung Cancer Res."},{"key":"6420_CR3","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","volume":"18","author":"M Perrot","year":"2017","unstructured":"Perrot M, Wu L, Wu M, Cho BCJ. Radiotherapy for the treatment of malignant pleural mesothelioma. Lancet Oncol. 2017;18:e532\u201342.","journal-title":"Lancet Oncol."},{"key":"6420_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12:763\u201372.","journal-title":"Lancet Oncol."},{"key":"6420_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.21037\/tlcr.2017.05.06","volume":"6","author":"Z Chen","year":"2017","unstructured":"Chen Z, Gaudino G, Pass HI, Carbone M, Yang H. Diagnostic and prognostic biomarkers for malignant mesothelioma: an update. Transl Lung Cancer Res. 2017;6:259\u201369.","journal-title":"Transl Lung Cancer Res."},{"key":"6420_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/SLA.0b013e3182602af4","volume":"256","author":"B Ghanim","year":"2012","unstructured":"Ghanim B, Hoda MA, Winter MP, et al. Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma. A retrospective multicenter analysis. Ann Surg. 2012;256:357\u201362.","journal-title":"Ann Surg."},{"key":"6420_CR7","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16:5805\u201313.","journal-title":"Clin Cancer Res."},{"key":"6420_CR8","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00432-013-1523-0","volume":"139","author":"ZH Yao","year":"2013","unstructured":"Yao ZH, Tian GY, Wan YY, Kang YM, Guo HS, Liu QH, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2013;139:2117\u201323.","journal-title":"J Cancer Res Clin Oncol."},{"key":"6420_CR9","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.cllc.2017.01.008","volume":"18","author":"S Takamori","year":"2017","unstructured":"Takamori S, Toyokawa G, Taguchi K, et al. The controlling nutritional status score is a significant independent predictor of poor prognosis in patients with malignant pleural mesothelioma. Clin Lung Cancer 2017;18:e303\u201313.","journal-title":"Clin Lung Cancer"},{"key":"6420_CR10","doi-asserted-by":"publisher","first-page":"41298","DOI":"10.1038\/srep41298","volume":"7","author":"N Li","year":"2017","unstructured":"Li N, Tian GW, Wang Y, Zhang H, Wang ZH, Li G. Prognostic role of the pretreatment C-reactive protein\/albumin ratio in solid cancers: a meta-analysis. Sci Rep. 2017;7:41298.","journal-title":"Sci Rep."},{"key":"6420_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.2147\/OTT.S137002","volume":"10","author":"HJ Xu","year":"2017","unstructured":"Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H. The prognostic value of C-reactive protein\/albumin ratio in human malignancies: an updated meta-analysis. OncoTargets Ther. 2017;10:3059\u201370.","journal-title":"OncoTargets Ther."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6420-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6420-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6420-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T19:02:52Z","timestamp":1551898972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6420-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["6420"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6420-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}